Status:
COMPLETED
A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Pediatric Pateints
Amnesic Properties of Propofol
Eligibility:
All Genders
4-14 years
Phase:
NA
Brief Summary
The goal of this study is to extend findings of propofol's effects on memory, as measured in volunteer research studies, to a clinical setting.
Eligibility Criteria
Inclusion
- The patient must be between 4 and 14 yrs of age and be undergoing a therapeutic or diagnostic procedure with or without sedation
- The patient must be able to comprehend and perform the task (naming pictures)
- The patient must have a minimum weight of 8 kg
Exclusion
- Allergy to propofol (for those patients requiring sedation)
- Procedure of short duration (\< 15 min)
- Pregnancy
- Recent use (within 5 half-lives) of centrally acting medications that could affect concentration (e.g. diphenhydramine)
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 10 2017
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT02278003
Start Date
February 1 2012
End Date
May 10 2017
Last Update
January 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065